Form EFFECT Kiniksa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 3, 2024 |
| Accession Number: | 0001104659-24-076396 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meet the AI Future: Fifth GDTE to Be Held in Hangzhou, Zhejiang
- Apeing Enters Stage 5 of Presale as Community-Focused Ethereum Token Surpasses $106,000 Raised
- Great Western Mining Corporation plc Announces Half-year Report
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
